Journey Medical Corporation logo

Journey Medical Corporation (DERM) Q1 2026 Earnings

DERM·Reported May 13, 2026·After market close

Journey Medical Corporation reported Q1 2026 revenue of $16.0M (+21.5% YoY), beat analyst consensus of $15.5M by $488.3K. Diluted EPS came in at $-0.08 (+55.6% YoY), missed the $-0.07 consensus by $0.01.

Revenue
$16.0Mbeat by $488.3K
Consensus: $15.5M
Diluted EPS
$-0.08missed by $0.01
Consensus: $-0.07
SEC

SEC Filings

Earnings release8-K · 0001104659-26-060232
Quarterly report10-Q · 0001104659-26-060297

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Journey Medical Corporation's Q1 2026 earnings report.

Journey Medical Corporation (DERM) reported Q1 2026 earnings on May 13, 2026 after market close.

Journey Medical Corporation reported revenue of $16.0M and diluted EPS of $-0.08 for Q1 2026.

Revenue beat the consensus estimate of $15.5M by $488.3K. EPS missed the consensus estimate of $-0.07 by $0.01.

Compared to the same quarter a year prior, revenue grew 21.5% from $13.1M a year earlier and diluted EPS grew 55.6% from $-0.18.

You can read the 8-K earnings release (0001104659-26-060232) and the 10-Q periodic report (0001104659-26-060297) directly on SEC EDGAR. The filing index links above go to sec.gov.